- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 93,900 | 10.07.24 18:16:38 | +1,700 | +1,84% | 93,650 | 93,900 | 91,700 | 92,200 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 970,600 | 10.07.24 08:02:09 | -11,000 | -1,12% | 977,800 | 984,600 | 970,600 | 981,600 |
